We are live on
!
Find out more
SCM
Sio Capital Management Portfolio holdings
AUM
$694M
1-Year Est. Return
79.73%
This Fund
S&P 500
This Quarter
Est. Return
+0.02%
1 Year Est. Return
+79.73%
3 Year Est. Return
+576.62%
5 Year Est. Return
+422.76%
10 Year Est. Return
+2,506.65%
AUM
$694M
AUM Growth
+$90.7M
(+15%)
Cap. Flow
+$121M
Cap. Flow
% of AUM
17.46%
Top 10 Holdings %
Top 10 Hldgs %
45.36%
Holding
89
New
20
Increased
24
Reduced
16
Closed
12
Top Buys
| 1 |
Cencora
COR
|
+$29.7M |
| 2 |
WAY
Waystar Holding Corp
WAY
|
+$27.3M |
| 3 |
Corcept Therapeutics
CORT
|
+$25.2M |
| 4 |
Icon
ICLR
|
+$24.5M |
| 5 |
Maximus
MMS
|
+$21.8M |
Top Sells
| 1 |
Cigna
CI
|
+$47.4M |
| 2 |
Sanofi
SNY
|
+$34.1M |
| 3 |
Celcuity
CELC
|
+$30.9M |
| 4 |
Zimmer Biomet
ZBH
|
+$29.6M |
| 5 |
Kenvue
KVUE
|
+$25.3M |
Sector Composition
| 1 | Healthcare | 92.9% |
| 2 | Industrials | 7.1% |
| 3 | Consumer Staples | 0% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
Maximus
MMS
$3.03B
| $49.3M | 7.1% |
768,825
+268,521
| +54% | +$21.8M |
|
|
WAY
2
Waystar Holding Corp
WAY
$4.26B
| $39.6M | 5.71% |
1,642,236
+1,028,511
| +168% | +$27.3M |
|
|
3
Icon
ICLR
$13B
| $33.9M | 4.89% |
306,358
+179,156
| +141% | +$24.5M |
|
|
4
Cencora
COR
$58.8B
| $31.7M | 4.57% |
100,894
+84,994
| +535% | +$29.7M |
|
5
Dianthus Therapeutics
DNTH
$5.54B
| $31.1M | 4.48% |
370,045
-104,458
| -22% | -$6.05M |
|
|
AVR
6
Anteris Technologies
AVR
$871M
| $29.9M | 4.31% |
5,382,965
+3,508,324
| +187% | +$20.2M |
|
|
7
Corcept Therapeutics
CORT
$9.71B
| $27.2M | 3.92% |
+674,759
| New | +$25.2M |
|
8
LivaNova
LIVN
$4.35B
| $26.8M | 3.86% |
421,615
+99,233
| +31% | +$6.4M |
|
9
Tyra Biosciences
TYRA
$1.96B
| $23.2M | 3.34% |
605,439
+79,437
| +15% | +$2.57M |
|
|
10
Celcuity
CELC
$5.42B
| $22.1M | 3.19% |
193,843
-283,224
| -59% | -$30.9M |
|
11
GSK
GSK
$103B
| $21.3M | 3.07% |
+385,879
| New | +$20.9M |
|
12
ANI Pharmaceuticals
ANIP
$1.83B
| $20.4M | 2.94% |
265,543
+178,271
| +204% | +$13.9M |
|
13
Abbott
ABT
$155B
| $19.2M | 2.76% |
+186,574
| New | +$21.1M |
|
14
Embecta
EMBC
$184M
| $16.3M | 2.35% |
+1,847,850
| New | +$19.3M |
|
|
ABVX
15
Abivax
ABVX
$11.8B
| $15.1M | 2.18% |
135,800
+92,676
| +215% | +$11M |
|
16
Vir Biotechnology
VIR
$1.6B
| $13.4M | 1.94% |
1,498,620
+1,020,277
| +213% | +$8.13M |
|
17
Haemonetics
HAE
$3.38B
| $12.4M | 1.79% |
220,672
+128,041
| +138% | +$8.34M |
|
|
SION
18
Sionna Therapeutics
SION
$1.92B
| $11.8M | 1.7% |
+294,340
| New | +$11.2M |
|
|
19
Sanofi
SNY
$103B
| $11.5M | 1.66% |
239,671
-732,015
| -75% | -$34.1M |
|
|
RAPP
20
Rapport Therapeutics
RAPP
$1.98B
| $11.5M | 1.65% |
366,809
+181,544
| +98% | +$5.11M |
|
21
Teleflex
TFX
$5.76B
| $11.3M | 1.63% |
94,800
+7,924
| +9% | +$874K |
|
22
BioMarin Pharmaceuticals
BMRN
$11.3B
| $11M | 1.58% |
194,226
-38,462
| -17% | -$2.24M |
|
23
Cross Country Healthcare
CCRN
$427M
| $10.3M | 1.49% |
1,098,393
+29,572
| +3% | +$265K |
|
24
Protara Therapeutics
TARA
$230M
| $10.3M | 1.48% |
1,969,839
+254,445
| +15% | +$1.51M |
|
25
Structure Therapeutics
GPCR
$3.6B
| $10.1M | 1.45% |
209,093
+7,593
| +4% | +$520K |
|
Similar funds
IIC
MCM
CGIC
HA
BBPWM
M
HG
CA